MedPath

江西科睿药业有限公司

Ownership
-
Established
2021-12-22
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

29

NMPA:29

Drug Approvals

Dronedarone Hydrochloride Tablets

Product Name
盐酸决奈达隆片
Approval Number
国药准字H20253890
Approval Date
Apr 15, 2025
NMPA

Compound Sodium Picosulfate Granules

Product Name
复方匹可硫酸钠颗粒
Approval Number
国药准字H20253774
Approval Date
Apr 1, 2025
NMPA

Perampanel Oral Suspension

Product Name
吡仑帕奈口服混悬液
Approval Number
国药准字H20253666
Approval Date
Mar 18, 2025
NMPA

Vancomycin Hydrochloride for Oral Solution

Product Name
口服溶液用盐酸万古霉素
Approval Number
国药准字H20253608
Approval Date
Mar 11, 2025
NMPA

Vancomycin Hydrochloride for Oral Solution

Product Name
口服溶液用盐酸万古霉素
Approval Number
国药准字H20253609
Approval Date
Mar 11, 2025
NMPA

Ibrutinib Capsules

Product Name
伊布替尼胶囊
Approval Number
国药准字H20253113
Approval Date
Jan 8, 2025
NMPA

Beraprost Sodium Tablets

Product Name
贝前列素钠片
Approval Number
国药准字H20253082
Approval Date
Jan 8, 2025
NMPA

Perampanel Tablets

Product Name
吡仑帕奈片
Approval Number
国药准字H20247284
Approval Date
Nov 12, 2024
NMPA

Regorafenib Tablets

Product Name
瑞戈非尼片
Approval Number
国药准字H20244729
Approval Date
Aug 27, 2024
NMPA

Brivaracetam Tablets

Product Name
布立西坦片
Approval Number
国药准字H20244272
Approval Date
Jun 28, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.